Invention Application
WO2017214321A1 CYSTEINE-OPTIMIZED STRADOMERS 审中-公开
半成品优化的STRADOMERS

CYSTEINE-OPTIMIZED STRADOMERS
Abstract:
The present disclosure involves biologically active proteins termed cysteine-optimized multimerizing stradomers. Thus, the present disclosure provides compositions and methods providing anti-autoimmune and anti-inflammatory activities, useful in the treatment of diseases and conditions including autoimmune diseases, inflammatory diseases, or infectious diseases.
Patent Agency Ranking
0/0